Comments on the new guidelines will be accepted until Sept. 18. “The Biden administration has been very vocal in saying they’re going to be very aggressive in the number of challenges and in trying novel theories of potential harm,” said Lauren Norris Donahue, partner and antitrust attorney in the Chicago office of K&L Gates. “It’s across all industries, but health care has been a focus of the Biden administration for enforcement actions.”
Read more:Congress Members Look To Strengthen Federal Privacy Laws In Medical Data
After a 30-day preliminary assessment, the vast majority of deals examined by the FTC and Department of Justice are authorized. But according to Ms. Donahue, a court injunction can be invoked to prevent two organizations from coming together for antitrust purposes, reported Post Gazette.
A non-binding letter of intent to pursue an affiliation with UPMC, a $26 billion healthcare and insurance behemoth with 95,000 employees, was signed by the board of directors of Washington Health System in June. The deal’s financial specifics were kept confidential.
The two federal agencies share enforcement duties and the draft guidelines are just that — non-legally binding principles used to analyze deals that “reflect some key themes the agencies have highlighted in recent cases and advocacy, including concerns about concentration of markets, serial acquisitions, competition in labor markets and practices by dominant firms that cement their position and harm competition,” according to an advisory from the law firm of Buchanan Ingersoll & Rooney PC.
Source: Post Gazette
Featured News
Democrats Question Big Tech Ballroom Donations Amid Antitrust Concerns
Dec 4, 2025 by
CPI
US Solicitor General Urges Supreme Court to Turn Away Duke Energy Antitrust Case
Dec 4, 2025 by
CPI
Russia Blocks Snapchat and FaceTime in Expanding Crackdown
Dec 4, 2025 by
CPI
Front Row Motorsports Owner Details Major Financial Losses in NASCAR Antitrust Trial
Dec 4, 2025 by
CPI
OpenAI Ordered to Turn Over Millions of ChatGPT Records in Ongoing Copyright Battle
Dec 4, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Intellectual Property
Nov 19, 2025 by
CPI
Dealing in Intellectual Property: IP Justifications and Defenses in Digital Markets Cases
Nov 19, 2025 by
Jennifer Dixton
The Evolving Role of Innovation Theories of Harm in the Antitrust Analysis of Life Science Mergers
Nov 19, 2025 by
Michelle Yost Hale, Matthew D. McDonald & Merrill Stovroff
Who Can Fix It? Antitrust, IP Rights, and the Right to Repair
Nov 19, 2025 by
Rosa M. Morales
Copyright, Antitrust, and the Politics of Generative AI
Nov 19, 2025 by
Daryl Lim